Literature DB >> 8772778

The epithelioid blue nevus. A multicentric familial tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma.

J A Carney1, J A Ferreiro.   

Abstract

We report on 21 pigmented nevi that occurred in 11 patients (6 male and 5 female patients) age 3 to 39 years. All patients had the Carney complex (myxomas, spotty skin pigmentation, endocrine overactivity, and schwannomas); six patients were members of three families. The nevi occurred on the extremities and trunk, less frequently on the head and neck, and were multiple in five patients. Clinically, they were darkly pigmented, domed, and small (less than 1 cm) and commonly interpreted as "blue nevi." Microscopically, they featured heavily pigmented, poorly circumscribed, dermal lesions that displayed two types of melanocytes: one intensely pigmented, globular, and fusiform; the other lightly pigmented, polygonal, and spindle. The melanocytes were situated among the dermal collagen bundles singly, in short rows and small groups, and occasionally in fascicles. Nuclei of the lightly pigmented, polygonal and spindle cells were vesicular with very pale chromatin and a single prominent nucleolus. Seven tumors were each part of a combined nevus. After excision, none of the tumors recurred or metastasized. The epithelioid blue nevus is important because of its strong association with the Carney complex. Therefore, affected patients (and their relatives) should be considered at risk for other elements of the syndrome, especially cardiac myxoma.

Entities:  

Mesh:

Year:  1996        PMID: 8772778     DOI: 10.1097/00000478-199603000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  25 in total

Review 1.  Carney complex: an update.

Authors:  Ricardo Correa; Paraskevi Salpea; Constantine A Stratakis
Journal:  Eur J Endocrinol       Date:  2015-06-30       Impact factor: 6.664

2.  Pigmented epithelioid melanocytoma: a new concept encompassing animal-type melanoma and epithelioid blue nevus.

Authors:  Paschalis Gavriilidis; Ilektra Michalopoulou; Kleopatra Chatzikakidou; Anastasia Nikolaidou
Journal:  BMJ Case Rep       Date:  2013-03-22

Review 3.  Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes.

Authors:  C A Stratakis
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

4.  Orbital and myocardial metastases of a primary pulmonary melanotic schwannoma.

Authors:  Robert Díaz Beveridge; Paula Richart Aznar; Cornelio Núñez Lozano; Melitina Chirivella Casanova; Miguel Corbellas Aparicio; Joaquín Montalar Salcedo
Journal:  Clin Transl Oncol       Date:  2010-07       Impact factor: 3.405

Review 5.  Problematic pigmented lesions: approach to diagnosis.

Authors:  S L Edwards; K Blessing
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

Review 6.  [Epithelioid and hyperpigmented melanocytic tumors. An overview].

Authors:  H Kutzner; L Schärer; L Requena
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

Review 7.  Carney complex and lentiginosis.

Authors:  Anelia Horvath; Constantine A Stratakis
Journal:  Pigment Cell Melanoma Res       Date:  2009-07-24       Impact factor: 4.693

8.  [Carney complex. Clinical, pathological and genetic features in two generations of a family].

Authors:  D Rothacker; C Kerber
Journal:  Pathologe       Date:  2008-07       Impact factor: 1.011

9.  Predominant formation of heavily pigmented dermal melanocytomas resembling 'animal-type' melanomas in hepatocyte growth factor (C57BL/6 x C3H)F1 mice following neonatal UV irradiation.

Authors:  Scott R Florell; Joshua Thomas; Douglas Grossman
Journal:  J Cutan Pathol       Date:  2007-09       Impact factor: 1.587

Review 10.  Biologically distinct subsets of nevi.

Authors:  Tova Rogers; Maria L Marino; Patricia Raciti; Manu Jain; Klaus J Busam; Michael A Marchetti; Ashfaq A Marghoob
Journal:  G Ital Dermatol Venereol       Date:  2016-04-27       Impact factor: 2.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.